Forian Inc. (NASDAQ:FORA) CEO Buys $32,894.40 in Stock

Forian Inc. (NASDAQ:FORA) CEO Max C. Wygod bought 12,320 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was bought at an average cost of $2.67 per share, with a total value of $32,894.40. Following the transaction, the chief executive officer now directly owns 1,324,500 shares of the company’s stock, valued at approximately $3,536,415. This trade represents a 0.94 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

Forian Price Performance

Shares of NASDAQ FORA opened at $2.76 on Friday. Forian Inc. has a 1-year low of $1.96 and a 1-year high of $4.15. The business has a 50-day moving average of $2.16 and a 200-day moving average of $2.20. The company has a market capitalization of $85.60 million, a price-to-earnings ratio of -30.67 and a beta of 1.06.

Institutional Investors Weigh In On Forian

Several institutional investors and hedge funds have recently modified their holdings of the stock. Elser Financial Planning Inc acquired a new position in shares of Forian in the fourth quarter worth about $1,151,000. Virtu Financial LLC acquired a new position in shares of Forian in the fourth quarter worth about $30,000. Renaissance Technologies LLC lifted its stake in shares of Forian by 48.9% in the fourth quarter. Renaissance Technologies LLC now owns 35,301 shares of the company’s stock worth $73,000 after acquiring an additional 11,601 shares in the last quarter. Finally, Canton Hathaway LLC lifted its stake in shares of Forian by 2.3% in the third quarter. Canton Hathaway LLC now owns 269,650 shares of the company’s stock worth $582,000 after acquiring an additional 6,125 shares in the last quarter. Hedge funds and other institutional investors own 19.25% of the company’s stock.

Analyst Ratings Changes

Separately, Roth Mkm reaffirmed a “buy” rating and issued a $5.00 target price on shares of Forian in a research report on Thursday, November 14th.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.